Skip to main content
World Journal of Gastroenterology logoLink to World Journal of Gastroenterology
letter
. 2009 Mar 7;15(9):1147. doi: 10.3748/wjg.15.1147

Lubiprostone: Clinical applications beyond constipation

Shailendra Kapoor 1
PMCID: PMC2655180  PMID: 19266613

Abstract

In comparison to polyethylene glycol, lubiprostone offers other advantages and is increasingly being used as an adjunctive agent in diagnostic as well as management strategies not only in gastroenterology, but in other fields. For instance, lubiprostone exerts beneficial effects in cystic fibrosis tissues. It augmernts the chloride secretion in these cells by activating non-cystic fibrosis transmembrane regulator (CFTR) secretion of chloride by afflicted respiratory epithelia. Lubiprostone also seems to improve visualization of the gastrointestinal tract during procedures such as colonoscopy. This is especially true if the lubiprostone is administered prior to bowel cleansing with agents such as polyethylene glycol electrolyte (PEG-E). Lubiprostone also enhances and stimulates contraction in colonic as well as gastric muscles and may thus further contribute as a prokinetic agent. Besides these effects, lubiprostone also causes hyperpolarization in other tissues such as uterine muscle cells. This may prove to be of significant clinical benefit in the management of uterine pathologies in the near future.

Keywords: Lubiprostone, Cystic fibrosis, Colonoscopy, Uterine muscle, Prokinetic agent

TO THE EDITOR

I read with great interest the recent article by Moeser et al[1]. The authors have provided an interesting comparison of lubiprostone and polyethylene glycol. In comparison with polyethylene glycol, lubiprostone offers other advantages and is increasingly being used as an adjunctive agent in diagnostic as well as management strategies not only in gastroenterology, but in other fields.

For instance, lubiprostone exerts beneficial effects in cystic fibrosis tissues. It augments the chloride secretion in these cells by activating non-cystic fibrosis transmembrane regulator (CFTR) secretion of chloride by afflicted respiratory epithelia[2]. Lubiprostone also seems to improve visualization of the gastrointestinal tract during procedures such as colonoscopy. This is especially true if the lubiprostone is administered prior to bowel cleansing with the agents such as polyethylene glycol electrolyte (PEG-E)[3]. Lubiprostone also enhances and stimulates contraction in colonic as well as gastric muscles and may, thus, further contribute as a prokinetic agent[4]. Besides these effects, lubiprostone also causes hyperpolarization in other tissues such as uterine muscle cells[5]. This may prove to be of significant clinical benefit in the management of uterine pathologies in the near future.

It is clear from the above examples that lubiprostone has an array of clinical features that may enhance its clinical application in gastroenterology. Further studies are needed to evaluate lubiprostone as an effective agent for the management of other diseases besides constipation.

Footnotes

S- Editor Cheng JX L- Editor Ma JY E- Editor Zheng XM

References

  • 1.Moeser AJ, Nighot PK, Roerig B, Ueno R, Blikslager AT. Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine. World J Gastroenterol. 2008;14:6012–6017. doi: 10.3748/wjg.14.6012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.MacDonald KD, McKenzie KR, Henderson MJ, Hawkins CE, Vij N, Zeitlin PL. Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice. Am J Physiol Lung Cell Mol Physiol. 2008;295:L933–L940. doi: 10.1152/ajplung.90221.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Stengel JZ, Jones DP. Single-dose lubiprostone along with split-dose PEG solution without dietary restrictions for bowel cleansing prior to colonoscopy: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008;103:2224–2230. doi: 10.1111/j.1572-0241.2008.02053.x. [DOI] [PubMed] [Google Scholar]
  • 4.Bassil AK, Borman RA, Jarvie EM, McArthur-Wilson RJ, Thangiah R, Sung EZ, Lee K, Sanger GJ. Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Br J Pharmacol. 2008;154:126–135. doi: 10.1038/bjp.2008.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cuppoletti J, Malinowska DH, Chakrabarti J, Ueno R. Effects of lubiprostone on human uterine smooth muscle cells. Prostaglandins Other Lipid Mediat. 2008;86:56–60. doi: 10.1016/j.prostaglandins.2008.03.001. [DOI] [PubMed] [Google Scholar]

Articles from World Journal of Gastroenterology : WJG are provided here courtesy of Baishideng Publishing Group Inc

RESOURCES